Voltz C, Fage D, Carter C
Synthelabo Recherche (L.E.R.S.), Department of Neurochemistry II, Rueil-Malmaison, France.
Eur J Pharmacol. 1994 Apr 1;255(1-3):197-202. doi: 10.1016/0014-2999(94)90098-1.
Ifenprodil (30 mg/kg i.p.) when administered alone did not antagonise the stimulatory effects of intrastriatally administered N-methyl-D-aspartate (NMDA: 500 microM, via a dialysis fibre) on spermine or spermidine release. The effects of NMDA were antagonised by the intrastriatal co-infusion of the glycine site antagonist, 7-chlorokynurenate (100 microM). Lower concentrations of 7-chlorokynurenate (3 microM) were without effect on the NMDA response. In the presence of a subthreshold concentration of striatally infused 7-chlorokynurenate (3 microM), systemically administered ifenprodil (30 mg/kg i.p.) blocked the effects of NMDA on polyamine release and also potentiated the inhibitory effects of 30 microM 7-chlorokynurenate. These results demonstrate that synergism between glycine antagonists and polyamine antagonists, as previously observed in vitro, is also observed in vivo.
单独给予艾芬地尔(腹腔注射30毫克/千克)时,并不拮抗纹状体内注射N-甲基-D-天冬氨酸(NMDA:500微摩尔,通过透析纤维)对精胺或亚精胺释放的刺激作用。NMDA的作用可被纹状体内共同注入甘氨酸位点拮抗剂7-氯犬尿氨酸(100微摩尔)所拮抗。较低浓度的7-氯犬尿氨酸(3微摩尔)对NMDA反应无影响。在纹状体内注入阈下浓度的7-氯犬尿氨酸(3微摩尔)的情况下,全身给予艾芬地尔(腹腔注射30毫克/千克)可阻断NMDA对多胺释放的作用,并且还增强了30微摩尔7-氯犬尿氨酸的抑制作用。这些结果表明,甘氨酸拮抗剂和多胺拮抗剂之间的协同作用,如先前在体外观察到的那样,在体内也能观察到。